Hailang He

557 total citations
30 papers, 442 citations indexed

About

Hailang He is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Hailang He has authored 30 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Hailang He's work include Lung Cancer Treatments and Mutations (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Hailang He is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Hailang He collaborates with scholars based in China, United States and Denmark. Hailang He's co-authors include Xianmei Zhou, Xianmei Zhou, Yong Xu, Fanchao Feng, Di Han, C. H. Turner, Cheng Gu, Jian‐Xin Li, Qian Wang and Qi Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Physical Review B and Journal of Medicinal Chemistry.

In The Last Decade

Hailang He

26 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hailang He China 14 181 133 62 57 42 30 442
Anne Marie Quinn United Kingdom 11 167 0.9× 178 1.3× 136 2.2× 22 0.4× 71 1.7× 16 524
Sijia Yang China 15 81 0.4× 183 1.4× 41 0.7× 53 0.9× 9 0.2× 62 577
Yuka Suzuki Japan 11 57 0.3× 184 1.4× 62 1.0× 76 1.3× 118 2.8× 28 647
Tsutomu Arai Japan 16 38 0.2× 145 1.1× 170 2.7× 55 1.0× 34 0.8× 35 575
Eric Mensier France 9 117 0.6× 94 0.7× 32 0.5× 64 1.1× 42 1.0× 13 351
Koichi Nishi Japan 11 99 0.5× 125 0.9× 43 0.7× 32 0.6× 17 0.4× 42 380
Yukio Satô Japan 11 59 0.3× 157 1.2× 30 0.5× 53 0.9× 27 0.6× 40 555
B. Dingle Canada 9 138 0.8× 23 0.2× 156 2.5× 100 1.8× 52 1.2× 18 408
Shin-ichi Nakamura Japan 14 58 0.3× 121 0.9× 70 1.1× 110 1.9× 11 0.3× 19 547

Countries citing papers authored by Hailang He

Since Specialization
Citations

This map shows the geographic impact of Hailang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailang He more than expected).

Fields of papers citing papers by Hailang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailang He. The network helps show where Hailang He may publish in the future.

Co-authorship network of co-authors of Hailang He

This figure shows the co-authorship network connecting the top 25 collaborators of Hailang He. A scholar is included among the top collaborators of Hailang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailang He. Hailang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tong, Hanhong Zhang, Bo Nancy Yu, et al.. (2025). Fuzheng Jiedu granules against disease progression among high-risk adults with non-severe COVID-19: a multicenter retrospective cohort study. Frontiers in Pharmacology. 16. 1523004–1523004.
2.
3.
4.
Xu, Yong, Fanchao Feng, Cheng Gu, et al.. (2021). Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 7 indexed citations
5.
Yang, Shuang, Yong Xu, Di Han, et al.. (2021). Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice. 45. 101470–101470. 5 indexed citations
6.
Wang, Zhichao, Fanchao Feng, Hailang He, et al.. (2021). Citrus alkaline extracts prevent endoplasmic reticulum stress in type II alveolar epithelial cells to ameliorate pulmonary fibrosis via the ATF3/PINK1 pathway. Phytomedicine. 89. 153599–153599. 18 indexed citations
7.
Li, Zhang, Wei Wang, Dian Wang, et al.. (2021). Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review. Respiratory Research. 22(1). 175–175. 34 indexed citations
8.
He, Hailang, Jing Wang, Li Zhang, et al.. (2021). Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 26. 2515690X211010733–2515690X211010733. 1 indexed citations
9.
Chen, Xinyue, et al.. (2020). Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology. 269. 113761–113761. 14 indexed citations
10.
He, Hailang, et al.. (2020). 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47) induces wide metabolic changes including attenuated mitochondrial function and enhanced glycolysis in PC12 cells. Ecotoxicology and Environmental Safety. 201. 110849–110849. 31 indexed citations
11.
12.
Feng, Fanchao, Qi Wu, Yihan Jin, et al.. (2019). Disodium Cantharidinate and Vitamin B6 Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 7 indexed citations
13.
Feng, Fanchao, Zhichao Wang, Qi Wu, et al.. (2019). Citrus alkaline extracts prevent fibroblast senescence to ameliorate pulmonary fibrosis via activation of COX-2. Biomedicine & Pharmacotherapy. 112. 108669–108669. 34 indexed citations
14.
He, Hailang, et al.. (2017). Shenfu Injection Adjunct with Platinum‐Based Chemotherapy for the Treatment of Advanced Non‐Small‐Cell Lung Cancer: A Meta‐Analysis and Systematic Review. Evidence-based Complementary and Alternative Medicine. 2017(1). 1068751–1068751. 17 indexed citations
15.
Huang, Chen, et al.. (2017). [Clinical analysis of rituximab-induced interstitial lung disease].. PubMed. 40(10). 730–735.
16.
Zhou, Xianmei, Dan Wang, Hailang He, et al.. (2017). Bone Marrow Derived Mesenchymal Stem Cells Involve in the Lymphangiogenesis of Lung Cancer and Jinfukang Inhibits the Involvement In Vivo. Journal of Cancer. 8(10). 1786–1794. 8 indexed citations
17.
He, Hailang, et al.. (2016). Jin Fu Kang Oral Liquid Inhibits Lymphatic Endothelial Cells Formation and Migration. Evidence-based Complementary and Alternative Medicine. 2016(1). 3635209–3635209. 6 indexed citations
18.
Fu, Hai‐Jian, Beihua Bao, Yang Zhao, et al.. (2014). Tryptophan Hydroxylase 1 (Tph-1)-Targeted Bone Anabolic Agents for Osteoporosis. Journal of Medicinal Chemistry. 57(11). 4692–4709. 39 indexed citations
19.
He, Hailang, et al.. (2013). Does the Couse of Astragalus-Containing Chinese Herbal Prescriptions and Radiotherapy Benefit to Non-Small-Cell Lung Cancer Treatment: A Meta-Analysis of Randomized Trials. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Marie Quinn Breakdown of academic impact, for papers by Sijia Yang Breakdown of academic impact, for papers by Yuka Suzuki Breakdown of academic impact, for papers by Tsutomu Arai Breakdown of academic impact, for papers by Eric Mensier Breakdown of academic impact, for papers by Koichi Nishi Breakdown of academic impact, for papers by Yukio Satô Breakdown of academic impact, for papers by B. Dingle Breakdown of academic impact, for papers by Shin-ichi Nakamura
Rankless by CCL
2026